CD24 and neoplasm: Multiple factors may influence the ICB response, including, but not limited to, the heterogeneity of the complex tumor microenvironment, such as tumor immune phenotypes or tumor-infiltrating lymphocyte patterns (47); tumor PD-L1 expression (48); and other “don’t eat me” signals like CD24 (49).